These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26248752)

  • 1. Liquid Biopsies Track DNA Changes in Tumors.
    Cancer Discov; 2015 Oct; 5(10):1009-10. PubMed ID: 26248752
    [No Abstract]   [Full Text] [Related]  

  • 2. New cancer blood test developed.
    Burki TK
    Lancet Oncol; 2018 Mar; 19(3):e140. PubMed ID: 29395866
    [No Abstract]   [Full Text] [Related]  

  • 3. Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids.
    Lewis JM; Heineck DP; Heller MJ
    Expert Rev Mol Diagn; 2015; 15(9):1187-200. PubMed ID: 26189641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis.
    Ferracin M; Negrini M
    Expert Rev Mol Diagn; 2015; 15(10):1369-81. PubMed ID: 26338209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry 2015: Protein correlates of molecular alterations and predictive testing.
    Hornick JL
    Semin Diagn Pathol; 2015 Sep; 32(5):323-4. PubMed ID: 26250936
    [No Abstract]   [Full Text] [Related]  

  • 7. Investors keep the faith in cancer liquid biopsies.
    Sheridan C
    Nat Biotechnol; 2019 Sep; 37(9):972-974. PubMed ID: 31485041
    [No Abstract]   [Full Text] [Related]  

  • 8. Fantastic voyage: the future of cancer diagnostics.
    Sundaresan TK; Haber DA
    Lancet Oncol; 2015 Dec; 16(16):1596-8. PubMed ID: 26678190
    [No Abstract]   [Full Text] [Related]  

  • 9. Predicting cancer: can we? Should we?
    Coburn C
    Lancet Oncol; 2016 Nov; 17(11):1494. PubMed ID: 27819231
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer biomarkers.
    Kucuk O
    Mol Aspects Med; 2015 Nov; 45():1-2. PubMed ID: 26187107
    [No Abstract]   [Full Text] [Related]  

  • 11. [Is Grail's goal feasible?].
    Jordan B
    Med Sci (Paris); 2016 Apr; 32(4):417-22. PubMed ID: 27137701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
    Gingras I; Salgado R; Ignatiadis M
    Curr Opin Oncol; 2015 Nov; 27(6):560-7. PubMed ID: 26335664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of DNA Integrity, Applications for Cancer Research.
    Zonta E; Nizard P; Taly V
    Adv Clin Chem; 2015; 70():197-246. PubMed ID: 26231488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conference scene: ISOBM 2013 in Israel: part 1: biomarkers - where we are now?
    Topolcan O; Pesta M; Svobodova S
    Biomark Med; 2013 Jun; 7(3):403-6. PubMed ID: 23734803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grail to pour $1 billion into blood test to detect early cancer.
    Sheridan C
    Nat Biotechnol; 2017 Feb; 35(2):101-102. PubMed ID: 28178244
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression and clinical value of the soluble major histocompatibility complex class I-related chain A molecule in the serum of patients with renal tumors.
    Zhao YK; Jia CM; Yuan GJ; Liu W; Qiu Y; Zhu QG
    Genet Mol Res; 2015 Jun; 14(2):7233-40. PubMed ID: 26125933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conference scene: ISOBM 2013 in Israel: part 2: biomarkers - a challenging issue for futher investigation.
    Topolcan O; Pesta M; Svobodova S
    Biomark Med; 2013 Jun; 7(3):407-14. PubMed ID: 23734804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy: still early days for early detection.
    Watts G
    Lancet; 2018 Jun; 391(10140):2593-2594. PubMed ID: 30070213
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic mirnas as potential biomarkers for malignancy.
    Healy NA; Heneghan HM; Miller N; Osborne CK; Schiff R; Kerin MJ
    Int J Cancer; 2012 Nov; 131(10):2215-22. PubMed ID: 22618667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells.
    Malara N; Coluccio ML; Limongi T; Asande M; Trunzo V; Cojoc G; Raso C; Candeloro P; Perozziello G; Raimondo R; De Vitis S; Roveda L; Renne M; Prati U; Mollace V; Di Fabrizio E
    Small; 2014 Nov; 10(21):4324-31. PubMed ID: 25044603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.